GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SHBI · Sep 30, 2025

SHORE BANCSHARES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001035092-25-000022Bank
Sequential deposit growth55thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

4.03% · CORE · VALID

Net-income growth55thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

28.23% · CORE · VALID

Interest-income growth10thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

3.34% · CORE · VALID

Cash and equivalents85thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$416.5M · CORE · VALID

Sequential loan growth45thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

1.14% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History54 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-2.68%
Current
4.03%
Delta
6.71%
Earnings Growth Decreased
Previous
38.04%
Current
28.23%
Delta
-9.80%
Interest Income Growth Decreased
Previous
4.81%
Current
3.34%
Delta
-1.46%
Liquidity Increased
Previous
$185.0M
Current
$416.5M
Delta
$231.5M
Loan Growth Increased
Previous
1.05%
Current
1.14%
Delta
0.08%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.